SBSohail Bade

Sohail Bade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sohail Bade has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The utility of SPECT-CT in identifying vertebral endplate changes for basivertebral nerve ablation: A retrospective study with MRI comparison

    by Eva Kubrova, Justin Schappell, Jeet Patel, Chris Radlicz, Rosalynn R.Z. Conic, Matthew A. Cascio, Robert Pagan-Rosado, Thomas M. Herrera, Jason S. Eldrige, Sebastian Encalada, et al.


  • GLP-1 agonists: a game changer in pain treatment and addiction

    by Sahil Bade, Mark Friedrich B. Hurdle, Sohail Bade, Sebastian Encalada, Sharima Kanahan-Osman, Sahil Gupta

    Chronic pain imposes a significant healthcare burden, with treatments often limited by side effects, opioid dependency, and preventable surgeries. Emerging evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs), developed for diabetes and obesity, may offer novel analgesia and treat drug-seeking behavior. This review examines the role of GLP-1RAs in pain management, focusing on inflammation, macrophage repolarization, oxidative stress, and dopaminergic pathways in substance use disorders. We conducted a literature search in PubMed and Embase (Ovid) from January 2000 to February 2025, identifying studies on GLP-1RA and pain in headaches, osteoarthritis, diabetic neuropathy, and substance use disorders. GLP-1RAs offer a promising shift in pain management, potentially reducing opioid dependence, preventing surgical interventions, and lowering healthcare costs. While early evidence suggests analgesic and disease-modifying effects beyond weight loss, significant knowledge gaps remain. In osteoarthritis, they appear to reduce inflammation and cartilage degradation, but trials in non-obese, non-comorbid patients are needed. In diabetic neuropathy, GLP-1RAs show potential for nerve repair, but optimal dosing and long-term efficacy need clarification. Preclinical data support GLP-1RAs signaling in migraines, but human studies are lacking. Trials in alcohol addiction show promise, though evidence for other substances remains inconclusive. Larger-scale trials are needed to confirm these findings.


  • Open Access

    Optimizing patient understanding of spine MRI reports using AI: A prospective single center study

    by Sebastian Encalada, Sahil Gupta, Christine Hunt, Jason Eldrige, John Evans, Johanna Mosquera-Moscoso, Laura Furtado Pessoa de Mendonca, Sharima Kanahan-Osman, Sohail Bade, Sahil Bade, et al.


  • Open Access

    Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex‐sumo wrestler

    by Sohail Bade, Sahil Bade, Grishma Sharma, Narayan Bhurtel, Yadvinder Singh, Sudip Paudel, Frena Pulami Magar, Kshitij Chapagain

    Key Clinical Message: Dulaglutide is a relatively unpopular GLP‐1 receptor agonist used for weight loss. This case demonstrates that dulaglutide may be beneficial for weight loss in morbidly obese patients with multiple comorbidities after thoroughly evaluating its efficacy, benefits, and long‐term adverse effects through clinical trials. We present a case of a 27‐year‐old ex‐sumo wrestler with bipolar II disorder, morbid obesity, hypertension, Type 2 Diabetes Mellitus (DM), and a Body Mass Index (BMI) of 49.66 kg/m2. He was non‐compliant with lifestyle modifications and resistant to conventional treatments, including metformin, and was also using multiple antipsychotic drugs. After introducing dulaglutide, he achieved a 40 kg (−21%) weight loss and a BMI reduction of 10.3 kg/m2 over 6 months, with no side effects and improved glycemic control, demonstrating dulaglutide's efficacy for weight loss in such challenging presentations.


  • Open Access

    ‘Dulaglutide induced weight loss in a morbidly obese adult with Type 2 diabetes mellitus: A Case Report’

    by Sohail Bade, Sahil Bade, Grishma Sharma, Narayan Bhurtel, Yadvinder Singh, Sudip Paudel, Frena Pulami Magar, Kshitij Chapagain

  • Open Access

    A survival case of high-dose amlodipine intoxication with non-cardiogenic pulmonary edema: a case report

    by Pankaj Pant, Sangam Shah, Ganesh Bhattarai, Krishnaa Dahal, Navindra Raj Bista, Sahil Bade, Kshitij Chapagain, Sohail Bade, Sagar Pant

    Introduction: Dihydropyridines calcium channel blockers at high dose can have conduction abnormalities, reduced inotropism, and non-cardiogenic pulmonary oedema (NCPE) which otherwise, at standard dosage have only vascular selectivity. They remain one of the commonly used anti-hypertensive exhibiting very lethal outcomes (50% mortality rates) in its overdose. Case presentation: The authors present a case of a 21-year-old male with amlodipine intoxication with 43 tabs of 10 mg (total of 430 mg) ingestion manifested by loss of consciousness, hypotension, tachycardia, and respiratory distress. Discussion: An amlodipine overdose causes refractory hypotension due to vasodilation and impaired cardiac metabolism and contractility. Further amlodipine toxicity can result in NCPE that manifests clinically as respiratory distress and low oxygen levels due to lung injury caused by inflammation and increased vascular permeability. Conclusion: This case report emphasizes the significance of early recognition and prompt treatment of amlodipine intoxication, which can result in serious complications like fluid overload and respiratory distress.


  • Open Access

    Case report of eventration of diaphragm due to an unknown febrile illness causing phrenic nerve palsy and other multiple nerve palsies

    by Pradhan P, R.M. Karmacharya, S Vaidya, A.K. Singh, P Thapa, P Dhakal, S Dahal, S Bade, N Bhandari

    Introduction: Diaphragmatic eventration can be congenital or acquired. Diagnosis is delayed due to no symptoms or very mild ones and is generally done by imaging modalities. This condition is managed by plication of the affected part of diaphragm by various surgical approaches. Presentation of case: A forty seven years lady presented with one year long history of abdominal pain, bloating and fullness after meals who was being treated in line of peptic acid disorder. She had developed bilateral foot drop after typhoid fever at seventeen years of age. Clinical examination and imaging with chest x-ray, chest ultrasound and computed tomography scan suggested eventration of left hemidiaphragm. Plication of eventration of left hemidiaphragm was done via mini thoracotomy of the left thorax. There were no postoperative complications and she was discharged on the sixth postoperative day. Discussion: Acquired eventration of diaphragm is commonly due to traumatic phrenic nerve palsy but rarely can be associated with a history of infection causing nerve palsies. Thoracic ultrasound is an emerging modality for diagnosis supporting X-rays and CT Scans. Plication of eventration with minimally invasive techniques has less number of hospital stay and less pain compared to open approaches. Conclusion: Non-traumatic diaphragmatic eventration due to acquired phrenic nerve palsy following an unknown febrile illness is a rare case to be reported in Nepal. The aim of treatment is expansion of intra-thoracic space which is done by plication of the diaphragm.